ELN 2022 AML Genetic Risk Classification
ELN 2022 AML Genetic Risk Classification - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the ELN 2022 AML Genetic Risk Classification → Runs in your browser. No signup, no tracking.
What this is
ELN 2022 AML Genetic Risk Classification is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. ELN 2022 AML Genetic Risk Classification - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345-1377. Read the source ↗
Worked example: ELN 2022 AML risk: Favorable — driven by mutated NPM1 without FLT3-ITD.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.